Empowering Women // Strengthening Families

918.4010.NFP

Tag Archives: Contraception

United Nations Commission on the Status of Women: Part 2

United Nations Commission on the Status of Women: Part 2

To read part 1, click here.

Tuesday morning, I made my way back to the Armenian Center to the Umuado Igbo Nigeria and in Diaspora’s event entitled “Managing the Challenges of Women and Girl Empowerment in Nigeria.” I found Francis who introduced me to the other women on her team. She handed me the program for the event and I saw that I was scheduled to be the FIRST panelist to speak! So much for my plan.

The event began, and I was introduced. I shared several of my points and some of the basics of how Billings education empowers women. I tried to emphasize that the method is effective, promotes respect of women across cultural boundaries, and that they can use the method within their culture to postpone or achieve pregnancy as they wish.

So many of the contraceptive programs offered to Africa come with forced ideological colonization. As the only white woman on the panel, I was keenly aware of my desire to empower them by offering information and walking alongside them to live the fullness of their culture without imposing mine.

The rest of the panelists spoke eloquently and emphasized the need for action rather than just talking about solving problems. As they spoke about the issues women face in their culture, I was even more humbled by realizing my own privilege.

During the question/answer time, a woman who was seated in the back stood up and introduced herself as Malcolm X’s youngest daughter. I am certain that the surprise on my face was evident as my mind raced to realize, “THAT Malcolm X?!” My slight awe quickly vanished as it became clear that she intended to try and take over the event by monopolizing the mic. She did, however, touch on the idea that action was needed, so when the moderator was able to take back the floor, she refocused onto this theme of the event.

Francis then directed a question toward me. “Women in Nigeria don’t use Billings because they don’t know how it works. What do we DO? How do we get started?” I explained that getting started is not difficult, but that all they would need is one trained teacher to teach a group of women to become instructors so that they can teach others, and it can ripple throughout the country. I also mentioned that Benin already has a WOOMB affiliate and that they may be an excellent resource for getting trainings started.

The members of the Umuado Igbo Nigeria and in Diaspora and event panelists

The members of the Umuado Igbo Nigeria and in Diaspora and event panelists

After the event, Francis expressed to me that she knew a Catholic woman who she was sure would be on board with this, and she is going to keep in touch with me to help them along the way. I also told her about the WOOMB International Conference to be held in Benin next year, and that it would be an excellent opportunity for those that they teach to become more connected and inspired.

These women were joyful, dynamic and lovely inside and out. As we chatted more, the moderator came over and I learned that she has seven children. I grabbed her hand and said, “Me too!” Francis laughed heartily and said, “So the one you are carrying will make 8? You should have two more and then you will have 10!” What a contrast to the shock and disdain of many in our culture at so many children. How beautiful to see their love and encouragement of large families!

Tuesday evening, three women from our team attended an NGO reception. It was an amazing opportunity for networking, and more informal discussions. The women in attendance were having a marvelous time, and were chatting up a storm. We talked to so many people, and were amazed at the openness of everyone to what WOOMB offers.

WOOMB teammates at the NGO reception

I also had an opportunity to speak with Susan O’Malley (Chair of the Executive Committee of CSW) that night. When I handed her out postcard she recognized it instantly, and remembered that we had asked for two parallel events, but she thought they had only approved one. I cheerfully announced that we had been given both events and how thankful we were for that opportunity. She shifted her weight to one leg, looked at me with skeptical eyes and said, “So, does it really work?” I smiled and confidently replied, “Yes, it actually does work!” I went on to explain a brief history of the Drs. Billings, Odeblad and Brown and Billings efficacy statistics. She shared that she had gotten pregnant on the IUD, Pill and trying the Rhythm method with the Pill. I quickly interjected, “Oh, now, we aren’t the rhythm method, the science is totally different.” I gave a very quick rundown of the ovarian hormones effects on the cervix and sensation, changing vs unchanging patterns. She thought for a moment, looked at the card again and said, “I need to go look at your website again, that’s interesting.”

I was thrilled at the length and honesty of our conversation.

Wednesday offered more opportunities for passing out postcards and networking. I spoke with a women from “Pleasant Gathering,” and was able to attend their parallel event. They are a faith based group from Nigeria who rescue women out of sex work and give them a marketable trade to make a living. They also were interested in how Billings education could help the women in their program.

As with the other women from Nigeria, these women were open and loving, grabbing me by the hand and leading me around to introduce me to everyone in their group.

Joy Ogbonnaya (head of Pleasant Gathering) and I


 

 

Allison, Shana and I in Times Square (plus random photo bomber), Allison’s Llama from the artisan fair, and me with Colbert

Wednesday afternoon provided a good opportunity to relax a little bit. We were able to find some treasures at the CSW Artisan Fair where women from all over the world brought their handmade items to sell. We also got to enjoy a little bit of New York by attending a taping of the Stephen Colbert Show, and walking through times square. It was a nice change of pace before gearing up for our last event in Thursday.

I spent Thursday morning passing out more postcards, and inviting people to our event. When it came time for us to begin, I was disheartened at the number of people in the room. I had talked to so many people that had expressed what seemed like a genuine interest in coming. But, my spirit lifted as time went on, and the room filled with familiar faces. I was excited to see Destiny Herndon De-La-Rosa (Founder of New Wave Feminists) come in. I had connected with her a few weeks before CSW and invited her to come. Allison did a fantastic job directing the event, and each panelist spoke well of their personal empowerment. Monica presented the slide rule excellently as well. The audience was engaged and again followed up with thoughtful questions. Even after the event had finished, we all stayed around talking for quite some time.

Me speaking at WOOMBs Thursday parallel event

Destiny (Founder of New Wave Feminists) and I

The WOOMB team went to dinner all together that evening to debrief from the week and get started planning for next year.

I am so very thankful for the opportunity to represent WOOMB International at

the United Nations for CSW63. I believe that the team this year was strong, supportive of one another, and effective in spreading our message. I look forward to being able to represent WOOMB to the UN in the future.

Thank you to all of you who supported me and helped me take the Billings Ovulation Method to the United Nations!

Share this:

Facebook Twitter Email Linkedin Tumblr

#ditchtherisk

#ditchtherisk

Articles that focus on the risks of contraception, only focus on one risk at a time, and always conclude that the benefits of contraception outweigh the risk. But the risks don’t come one at a time. Weigh carefully! ‪#‎Ditchtherisk‬

Articles that focus on the risks of contraception, only focus on one risk at a time, and always conclude that the benefits of contraception outweigh the risk. But the risks don't come one at a time.  Weigh carefully! ‪#‎Ditchtherisk‬

 Women deserve better; You deserve better.

The great news is, you do not have to fill your body with harmful steroids in order to postpone a pregnancy!

The Billings Ovulation Method® is 100% risk free and 99.5% effective. Billings is a method of natural fertility management developed by Neurologist, Dr. John Billings, in 1953. With help from Pediatrician, Dr. Lyn Billings, Biophysicist, Dr. Erik Odeblad (the father of the MRI), and Endocrinologist, Dr. James Brown. The method is based on the observation of one simple symptom, day by day, making it simple for every woman to recognize her patterns of fertility. This includes you, even if you experience irregular cycles, even if you’re a postpartum mom, even if you’re approaching menopause. If you have been diagnosed with PCOS or Endometriosis you can still effectively use the method, and because of the extensive research, the method can even help you pinpoint the cause of your ovarian dysfunction.

Simple. Scientific. Effective. Health monitoring. Zero side effects, 100% risk free.

Why settle for less? Contact us today to schedule your free informational session.


Feel free to print this as a poster provided that the image is not altered and the copyright is left intact.

Share this:

Facebook Twitter Email Linkedin Tumblr

What’s Up with Ella?

The department of Health and Human Services (HHS) clarified the contraception coverage in the Affordable Care Act last week. Initially, HHS relied on “good faith” that insurance companies would cover contraception at no cost to the patient. This new clarification specifies that one medication from each of 18 specific categories of contraception must be covered at no cost. The 18 categories are predictable including combination hormonal contraceptives, progestin only pills, IUDs, and more. The final category, however, seems out of place and warrants a second look. This category contains only one drug — Ella.

Ella is a fairly new medication being marketed as an emergency contraceptive. They call it the “week after pill.” Why then is Ella in its own category, separated from other emergency contraceptives? And why of the 18 categories, is Ella the only one identified by the name of the medication, rather than a type?

The simple answer is that Ella’s mechanisms of action are different than other emergency contraceptives (ECs) like Plan B and One-Step. Other ECs contain synthetic progestins like levonorgestrel. Only differing with progestin only pills in dosage, these ECs behave in a similar way to regular hormonal contraception. By inundating the body with large amounts of extra hormones all at once ECs can delay ovulation, block sperm and thin the lining of the endometrium making it inhospitable to implantation. 1

Ella, on the other hand, contains 30mg of ulipristal acetate, and is categorized as an Selective Progesterone Receptor Modulator (SPRM). The FDA has only approved two SPRMs to date: Mifepristone (RU-486) and Ella 2
(although SPRMs are being investigated for other uses regarding reproductive health).

The drugs are certainly not identical, but their placement in the same category should make us curious, and spur further examination. Mifepristone is an antagonist SPRM and it is used to terminate a pregnancy before 20 weeks gestation by blocking the body’s ability to appropriate 3 the progesterone needed to continue a pregnancy. 4 Ella is said to be incapable of this, but it is classified as both an agonist and antagonist SPRM. The main mechanism of action of Ella is (due to its agonist properties) to delay ovulation, and if ovulation were to occur, it attempts to create a luteinized unruptured follicle (LUF: i.e. keep the egg in it’s casing, which makes it impossible for fertilization to take place). Ella also decreases the thickness of the endometrium making it difficult for a fertilized egg to implant. 5 These traits make Ella very similar to other ECs. But Ella, like Mifepristone, is also an antagonist SPRM and is similarly able to bind to the progestin receptors, although its effects are not as potent.

In an article published in McGraw Hill’s Access Medicine, Dr. Stephen R. Hammes writes, “As may be expected, ulipristal has also provoked an adverse reaction in the United States by opponents of the termination of pregnancy.” Hammes goes on to explain the mechanisms of action for the drug saying, “Ulipristal is known to have anti-proliferative effects in the uterus at high doses; however, its most relevant actions to date are its ability to inhibit ovulation.” (While inhibiting ovulation may be the most relevant mechanism, it does not negate the drug’s other mechanisms). He concludes his article with this warning, “The drug should not be taken by women who are breastfeeding or who are pregnant and wish to remain so” (emphasis added).6

Ella’s ability to terminate an existing pregnancy is seen in animal trials of its only ingredient, Ulipristal Acetate. The European Medical Association says, “Ulipristal, mifepristone and lilopristone were approximately equipotent at the dose levels of 10 and 30 mg/day in terminating pregnancies in guinea-pigs when the animals were treated on days 43 and 44 of gestation.” In monkey trials half of the fetuses died when given Ulipristal Acetate in the first month of pregnancy.7

Admittedly, these animals were given a higher dosage of Ulipristal Acetate than Ella gives a human in one dose, but the drugs ability to bind progesterone receptors in an antagonist way, regardless of dosage, is significant. Anyone who has suffered miscarriage can tell you the importance of progesterone in the early stages of pregnancy.8 Low progesterone is cited as a major influence in the continuation of a pregnancy. 9 While progesterone is not completely blocked by Ella, it certainly is inhibited. Any inhibition of progesterone is likely to affect an “established pregnancy” and at higher doses, Ella is just as effective as Mifepristone.

Ella creates its own category in the HHS contraception coverage because its action as an “emergency contraceptive” is significantly different than other ECs. And now, it is available at no cost to the American public. Moreover, being the only drug in the category ensures government enforced subsidization of Ella’s manufacturer Afaxys.

This information should be no more infuriating than the fact that all 18 categories of pharmaceutical contraceptives act in a way that can cause a fertilized egg to be expelled from the body. More on this topic here and here.

  1. “Emergency Contraception (Morning After Pill).” Emergency Contraception (Morning After Pill). Accessed May 21, 2015. https://web.archive.org/web/20100809110008/http://www.plannedparenthood.org/health-topics/emergency-contraception-morning-after-pill-4363.htm#.
  2. Bastianelli, Carlo, and Manuela Ferris. “Emergency Contraception.” Expert Rev of Obstet Gynecol 6, no. 5 (2011): 569-76.
  3. Olive, DL. “Role of Progesterone Antagonists and New Selective Progesterone Receptor Modulators in Reproductive Health.” Obstet Gynecol Surv. 57, no. 11 (2002): S55-63.
  4. “Prescribing Information.” : Mifeprex (mifepristone) Medical Abortion Pill (ru486). Accessed May 21, 2015.
  5. “Ella Full Prescribing Information.” Accessed May 21, 2015. http://www.ellanow.com/pdf/ella-full-prescribing-information.pdf.
  6. Hammas, Stephen R., and Laurence L. Brunton. “Ella: A Newly-Approved Selective Progesterone Receptor Modulator.” Access Medicine from McGraw Hill. Accessed May 21, 2015. http://www.medscape.com/viewarticle/735277.
  7. “CHMP Assessment Report for Ellaone.” European Medicines Agency Evaluation of Medicines for Human Use, 2009. Accessed May 20, 2015. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001027/WC500023673.pdf
  8. DAYA, S. (1989), Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. BJOG: An International Journal of Obstetrics & Gynaecology, 96: 275–280. doi: 10.1111/j.1471-0528.1989.tb02386.x
  9. “Causes.” Pregnancy Loss. Accessed May 21, 2015. http://www.pregnancyloss.info/causes.htm.
Share this:

Facebook Twitter Email Linkedin Tumblr

Rachel Held Evans (a self professed pro-life, woman of faith, Christian feminist) recently wrote a blog entitled “Privilege and the Pill.” She wished to express her opinion, “as a pro-life woman of faith who supports affordable access to birth control.” Denny Burke and Andrew Walker wrote a response here 1 addressing the political concerns which prompted her blog. However, there were many additional points in Mrs. Evan’s piece that needed to be addressed. Continue reading

Share this:

Facebook Twitter Email Linkedin Tumblr

The following article is not meant to endorse or disparage any political position or candidate. Rather, it is meant to help us examine ourselves and motives in the light of a recent events.

During a recent appearance on Fox News’ “Huckabee,” presidential hopeful Mitt Romney stated that he was in favor of the Personhood Amendment, which declares that human life begins at conception. Shortly after this, Romney was at a town hall meeting in Iowa[1] where a woman stood up and voiced her concern that the Personhood Amendment would outlaw hormonal contraception, which is used by millions of women. Without missing a beat, Romney responded that he was not against hormonal contraception. He was against anything that effected life after conception, “contraception prevents conception. I am not against that.” The concerned citizen continued and urged Romney to have staff look into this statement because it is known that hormonal contraception prevents implantation, not always conception. He smiled, said thank you and changed the subject. Continue reading

Share this:

Facebook Twitter Email Linkedin Tumblr

Clinical Trials: IUD vs. Billings Ovulation Method™

In July 2011, the American Journal of Obstetrics and Gynecology released a pamphlet stating several doctors’ endorsement of Intrauterine Devices (IUD) as “as safe and effective birth control.” IUDs were once unpopular in the United States, nevertheless, use has persevered. Physicians are starting to recommend IUDs more frequently, especially non-hormonal, copper IUDs. However, as Delicia Yard of ClinicalAdvisor.com points out, “The devices may raise the risk of pelvic inflammatory disease and subsequent infertility.” Prescribing information for a popular IUD lists these common side effects: headache, abdominal/pelvic pain, irregular bleeding, depression, migraine, nausea, acne, back pain, genital tract infection, ovarian cysts, dysmenorrheal, breast pain, and unintentional expulsion of the device. Despite this, it has been said that IUDs are “the most cost-effective form” of birth control available.

How does this newly popularized birth control stand up to the Billings Ovulation Method™ (BOM)? Continue reading

Share this:

Facebook Twitter Email Linkedin Tumblr

What They Won’t Tell You About Male Contraceptives

Recently, the news has been full of stories on a contraceptive medication for males. Researchers seek to “even the playing field” when it comes to contraception options. Development of a male birth control pill is being explored, but many methods being considered are not pills at all. No matter the prescription, there are some important things to know about the options being pursued.

Continue reading

Share this:

Facebook Twitter Email Linkedin Tumblr

Real Control

Real Control

I have just been doing my daily research on birth control/family planning in the news. I come across all kinds of interesting studies and articles. Today I found one called, “My Big Fat Feminist Pregnancy.” I debating taking the time to read it, but decided to see what this feminist was writing about. It all centers around control: control of one’s body, control of ones decisions, control of one’s fertility, control of one’s career after children… CONTROL. She is not combative about it, but I read it feeling sad for this woman. Sad that she sees the only way of “controlling” fertility is the pill, sad that she fears her beloved career suffering because of her baby. Here are my responses…
Continue reading

Share this:

Facebook Twitter Email Linkedin Tumblr